Cargando…
Three agonist antibodies in combination with high-dose IL-2 eradicate orthotopic kidney cancer in mice
BACKGROUND: Combination immunotherapies can be effective against subcutaneous tumors in mice but the effect against orthotopic malignant disease is less well characterized. In particular, a combination of three agonist antibodies, termed Tri-mAb, consisting of anti-DR5, anti-CD40 and anti-CD137 has...
Autores principales: | Westwood, Jennifer A, Darcy, Phillip K, Guru, Preethi Mayura, Sharkey, Janelle, Pegram, Hollie J, Amos, Sally M, Smyth, Mark J, Kershaw, Michael H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873376/ https://www.ncbi.nlm.nih.gov/pubmed/20426873 http://dx.doi.org/10.1186/1479-5876-8-42 |
Ejemplares similares
-
Routes of Delivery for CpG and Anti-CD137 for the Treatment of Orthotopic Kidney Tumors in Mice
por: Westwood, Jennifer A., et al.
Publicado: (2014) -
Environmental enrichment does not impact on tumor growth in mice
por: Westwood, Jennifer A, et al.
Publicado: (2013) -
Clinical application of genetically modified T cells in cancer therapy
por: Kershaw, Michael H, et al.
Publicado: (2014) -
Intracorporeal Orthotopic Neobladder: Est Modus in Rebus
por: Guru, Khurshid A.
Publicado: (2021) -
Enhancing immunotherapy using chemotherapy and radiation to modify the tumor microenvironment
por: Kershaw, Michael H, et al.
Publicado: (2013)